Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 2.2036.8263.14-3.4820.95

What is the latest Core EBITDA Growth ratio of ORCHID PHARMA ?

The latest Core EBITDA Growth ratio of ORCHID PHARMA is 2.20 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar20252.20
Mar202436.82
Mar202363.14
Mar2022-3.48
Mar202120.95

How is Core EBITDA Growth of ORCHID PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 2.2
-94.02
Mar2024 36.82
-41.69
Mar2023 63.14
Positive
Mar2022 -3.48
Negative
Mar2021 20.95 -

Other Financial Ratios of ORCHID PHARMA


Compare Core EBITDA Growth ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹3,580.2 Cr -1.1% -9.5% -51.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,197.0 Cr 0.9% -0.2% -12.5% Stock Analytics
DIVIS LABORATORIES ₹159,634.0 Cr 0.1% 0.4% 16.6% Stock Analytics
CIPLA ₹126,082.0 Cr 0.5% 3.8% -3.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,167.0 Cr NA -0.9% 4.9% Stock Analytics
DR REDDYS LABORATORIES ₹108,783.0 Cr 2.8% 6.9% -2% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-1.1%

-9.5%

-51.4%

SENSEX

1%

2.1%

0.5%


You may also like the below Video Courses